TW200509963A - Anti-infective composition against parvoviral infections - Google Patents

Anti-infective composition against parvoviral infections

Info

Publication number
TW200509963A
TW200509963A TW093115407A TW93115407A TW200509963A TW 200509963 A TW200509963 A TW 200509963A TW 093115407 A TW093115407 A TW 093115407A TW 93115407 A TW93115407 A TW 93115407A TW 200509963 A TW200509963 A TW 200509963A
Authority
TW
Taiwan
Prior art keywords
infections
parvoviral infections
parvoviral
parvovirus
egg
Prior art date
Application number
TW093115407A
Other languages
Chinese (zh)
Inventor
Yoshikatsu Kodama
Hideo Goshima
Original Assignee
Ghen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghen Corp filed Critical Ghen Corp
Publication of TW200509963A publication Critical patent/TW200509963A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The object of the present invention is to provide anti-infective compositions and petfoods against parvoviral infections effective in preventing and treating parvoviral infections, which effectively prevent the onset of parvoviral infections in pets, and also effectively ameliorate symptoms characteristic of parvoviral infections such as diarrhea, emesis, and body weight loss. The present invention provides eggs produced by avians immunized with parvovirus or antigens derived from parvovirus or a processed product of the egg, wherein the neutralizing antibody liter of the egg or processed product thereof is 256 folds or more.
TW093115407A 2003-05-30 2004-05-28 Anti-infective composition against parvoviral infections TW200509963A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003154825A JP2004352693A (en) 2003-05-30 2003-05-30 Anti-parvovirus infection composition

Publications (1)

Publication Number Publication Date
TW200509963A true TW200509963A (en) 2005-03-16

Family

ID=33487335

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093115407A TW200509963A (en) 2003-05-30 2004-05-28 Anti-infective composition against parvoviral infections

Country Status (3)

Country Link
JP (1) JP2004352693A (en)
TW (1) TW200509963A (en)
WO (1) WO2004105792A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007084495A (en) * 2005-09-22 2007-04-05 Daikin Ind Ltd Method for treating virus-infected cell
GB201404503D0 (en) 2013-07-09 2014-04-30 Mars Inc Canine health product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195631B2 (en) * 1991-02-16 2001-08-06 太陽化学株式会社 Method for producing specific chicken egg antibody
JPH08259462A (en) * 1994-12-05 1996-10-08 Adtec Kk Antiparbovirus infectious disease composition
JPH10265393A (en) * 1997-03-25 1998-10-06 Natl Fedelation Of Agricult Coop Assoc Medicine for preventing and treating porcine epidemic diarrhea
CZ287956B6 (en) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Peroral preparation intended for prevention and treatment of canine parvovirus infection

Also Published As

Publication number Publication date
JP2004352693A (en) 2004-12-16
WO2004105792A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
PH12019500097A1 (en) Combination comprising a fungicidal strain and an active compound
WO2005103084A3 (en) Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
BRPI0414062A (en) use of midified cyclosporins for the treatment of hcv disorders
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
ATE321836T1 (en) AQUEOUS COMPOSITIONS FOR SURFACE TREATMENT
WO2001098317A3 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
WO2007067416A3 (en) Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
WO2006133396A3 (en) Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
WO2009117030A3 (en) Improved compositions for the prevention and treatment of smallpox
WO2006031610A3 (en) Bicyclic anilide spirolactam cgrp receptor antagonists
MA33541B1 (en) NOVEL BIOPESTICIDAL COMPOSITIONS AND METHOD OF ISOLATION AND CHARACTERIZATION
WO2006091929A3 (en) Alkali resistant glass compositions
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
NZ613923A (en) Antibody compositions that bind polypeptides from staphylococcus aureus
WO2007044411A3 (en) Anti-myostatin antibodies
ES2093906T3 (en) SELF-DISPERSIBLE COMPOSITIONS IN WATER CONTAINING ORGANOPOLISILOXANES.
WO2008039169A3 (en) Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens
EP1856100A4 (en) Cgrp receptor antagonists
WO2006044449A3 (en) Cgrp receptor antagonists
MY128138A (en) Method for fighting against arthropods destructive of crops and compositions therefor
WO2007039788A8 (en) Composition and methods for inhibiting h. pylori adhesion and infection
DE602004028592D1 (en) AGAINST CLOSTRIDIUM DIFFICILE DIRECTED ANTIBODIES
TW200509963A (en) Anti-infective composition against parvoviral infections
HK1098077A1 (en) Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
BRPI0214180B8 (en) synergistic fungicidal composition, curative or preventive control method and product